Clinical Trials in Houston

Showing 6501-6520 of 17,885 trials

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

NCT01471106

The goal of this clinical research study is to learn if dasatinib can help prevent breast cancer from developing in the unaffected breast. Dasatinib is designed to decrease the activity of one or more proteins that are responsible for the uncontrolled growth of tumor cells. This is an investigational study. Dasatinib is FDA approved and commercially available for the treatment of leukemia. Its use in breast cancer patients in investigational. Up to 66 patients will take part in this multicenter study. Up to 60 will be enrolled at MD Anderson.

Breast Cancer

M.D. Anderson Cancer Center26 participantsStarted Jan 2014

Durham, North Carolina, United States • Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

NCT00992459

This was a randomized, active-controlled, double-blind, cross-over study designed to enroll subjects with UCDs who are being treated with NaPBA.

Urea Cycle Disorders

Amgen46 participantsStarted Oct 2009

Long Beach, California, United States • Los Angeles, California, United States • Stanford, California, United States +19 more locations

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

Find Trials by Condition in Houston

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor

TARGET Post-Approval Study

Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Ambispective Clinical Evaluation of Sophono™

Vibrant Capsule vs. Placebo for Patient Suffering From Constipation